Curriculum vitae

CURRICULUM VITAE

NAME: DANIEL S. ARICK, M.D., F.A.C.S.

SPECIALITY:

LICENSURE:

BOARD CERTIFICATION:
Diplomate, American Board of Otolaryngology - Head and Neck Surgery
SOCIETIES:

RESIDENCES:

TEACHING APPOINTMENTS: Clinical Assistant Professor, Department of
Otolaryngology/College of Medicine, State University of New York Health Science Center in Brooklyn, Downstate
HOSPITAL APPOINTMENTS:
The New York Eye & Ear Infirmary, New York, New York
PRIVATE PRACTICE:

PUBLICATIONS
I.
Arick, D.S, Silman S.(2005) Nonsurgical Home Treatment of Middle Ear Effusion and Associated Hearing Loss in Children. Part I: Clinical Trial. Ear, Nose and Throat Journal, Vol. 84, No.9, September, 2005, pp.567-578 Silman, S., Arick, D.S.(2005) Nonsurgical Home Treatment of Middle Ear Effusion and Associated Hearing Loss in Children. Part II: Validation Study. Ear, Nose and Throat Journal, Vol. 84, No.10, October, 2005, pp.646-654 Arick D.S., Silman S. (2000). Treatment of Otitis Media With Effusion based on Politerization With an Automated Device. Ear, Nose and Throat Journal April:290-298. Silman S., Arick D.S. (1999). Efficacy of Modified Politzer Appartus in Management of Eustachian Tube Dysfunction in Adults. Journal of the American Academy of Audiology 10:496-501 Arick D.S. (1995) Diagnosis and treatment of otitis media, Seminars in Hearing 16 (1):20-27 Arick D.S. (19940 Pure-tone assessment and screening of children with middle ear effusion. Co-authored with Silman and Silverman). Journal of American Academy of Audiology 5:173-182. Arick D.S (1992) Acoustic immittance screening for detection of middle-ear effusion in children. (Co-authored with Silman and Silverman). Journal of American Academy of Audiology 3:262-268. Arick, D.S., Silman S. Early detection of acoustic tumors. II. RESEARCH
Clinical Investigator for Pfizer Pharmaceuticals: participated in clinical trials on the antihistamines Medical consultant, Federal Grant No. 002 ($300,000) awarded to Silman et al., Brooklyn College, CUNY by the Department of Rehabilitation Research and Development, U.S. Department of Veterans Affairs (1992 - 1993). Effects of lack of amplification on audition. Medical consultant, Federal Grant No. 003 ($400,000) awarded to Silman et al. Brooklyn College, CUNY by the Department of Rehabilitation Research and Development, U.S. Department of Veterans Affairs (1992 - 1995). Effects of lack of amplification on unilateral hearing loss. III. PATENTS
Arick D.S. and Silman S. “Apparatus and Method For Equalizing the Pressure in the Middle Ear”, Patent No.: 5,419.762, Patent Issued: May 30, 1995 (EarPopper) Arick D.S. and Silman S. “Apparatus For Equalizing the Pressure in the Middle Ear”, Patent No. 5,885,242 Patent Issued: March 23, 1999 (EarPopper) F.D.A. 510K Approved (EarPopper) Arick D.S. “Emergency Cricothyrotomy Tube Insertion”, Patent No.: 5,681,323, Patent Issued: October 28, 1997. IV. GRANTS
Principal Investigator: National Institutes of Health: Awarded a Phase I S.B.I.R. grant for prototype development and feasibility study using EarPopper device to treat otitis media with effusion and related medical conditions. Awarded: July, 1998 Principal Investigator: National Institutes of Health: Awarded a Phase II Grant for clinical trial using EarPopper device to treat otitis media with effusion in children. ($1,000,000) Awarded: August, 2001

Source: http://www.danarickmd.com/cv.pdf

Altana fax standard

ALTANA AG Postfach 1244 T +49 (0) 6172 1712-160 F +49 (0) 6172 1712-158 ALTANA mit gutem Start im 1. Quartal 2005 Umsatz +4%; Konzerngewinn +4% Starkes Pharmageschäft Bad Homburg, 28. April 2005 – Die ALTANA AG (FWB: ALT, NYSE: AAA) hat im ersten Quartal 2005 den Konzernumsatz um 4% auf 741 Mio. € gesteigert. Bereinigt um Desinvestitions- und Währungseffekte e

Sobre inscripción estatal de entidades jurídicas y sucursales y oficinas de representación

Sobre inscripción estatal de entidades jurídicas y sucursales y oficinas de representación Ley de la República de Kazajstán de 17 de abril de 1995 N 2198 (con modificaciones y anexos según el estado para el 21.06.2013) Artículo 1. Concepto de inscripción estatal de las entidades jurídicas y las sucursales y oficinas de representación La inscripción estatal de las entidades

Copyright © 2010-2018 Pharmacy Drugs Pdf